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Background
Minority viral populations present in very low abundance
(<1%) are difficult to analyze by conventional sequencing
analysis. Therefore, the biological implication of these
rare variants has not been fully realized.
Methods
To precisely quantify frequencies of low abundance vari-
ants, we characterized a large number of viral genomes
from three HIV-1 infected individuals using a newly
developed parallel allele-specific sequencing (PASS) assay
that can simultaneously analyze thousands of viral
genomes at multiple nucleoside positions and perform
linkage analysis for those sites. Several unique positions
(8–15) on each genome were analyzed among hundreds
or thousands of viral genomes from each sample to deter-
mine minority viral populations.
Results
Eight potential T cell escape mutations were identified by
SGA sequences (7–13 per sample) after comparing the
whole genome sequences obtained at screening, enrol-
ment and various weeks (1–48) after enrolment in
CH0131. To determine if such mutations were present at
screening (antibody undetectable), we analyzed 1,853
partial env  genes using the PASS assay and found two
(0.11%) carrying potential T cell escape mutations. Anal-
ysis of 6,556 nef gene sequences showed 10 and 25 poten-
tial escape mutations (0.15% and 0.38%) at two
independent Nef epitopes, respectively. Linkage analysis
between independent nucleoside sites revealed numerous
unique recombinant genomes at low frequencies (<1%)
at the acute infection stage in two individuals (CH0047
and CH0200) infected with multiple transmitted viruses.
In CH0200, PASS analysis of 821 viral genomes also iden-
tified three additional transmitted viruses present only at
2.3%–4.0% of the viral population.
Conclusion
The data indicate that some T cell escape mutations may
exist at low frequencies in the early stage of the infection
and are selected later. The PASS assay may serve as a useful
method to detect low frequencies of T cell escape mutants,
recombinant genomes, and minority transmitted viruses
in HIV-1 infected individuals.
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